Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline

NCT01400425 is registered in ClinicalTrials.gov with Avid Radiopharmaceuticals as lead sponsor.

NCT NCT01400425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01400425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline
Lead sponsor
Avid Radiopharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2011
Completion date
July 31, 2012
Enrollment
239 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

progressive cognitive decline